A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F.

A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F.
复制标题

DOI:
10.3389/fphar.2018.00104
复制
发表时间:
2018
影响因子:
5.6
通讯作者:
Wang Y
Wang Y
中科院分区:
医学2区
文献类型:
--
作者:
Chen SR;Dai Y;Zhao J;Lin L;Wang Y;Wang Y

文献摘要

参考文献

被引文献

相似文献

雷公藤内酯醇和雷公藤红素是从药用植物雷公藤中分离得到的主要活性天然产物。这些化合物显示出相似的药理活性,包括抗癌、抗炎、抗肥胖和抗糖尿病活性。雷公藤内酯醇和雷公藤红素还提供神经保护,预防心血管和代谢疾病。然而,毒性限制了雷公藤内酯醇和雷公藤红素的进一步开发。本文就雷公藤内酯醇和雷公藤红素的治疗靶点、作用机制及翻译研究作一综述。本文系统地讨论了雷公藤内酯醇、雷公藤红素及其衍生物的构效关系。此外,我们建议使用结构衍生物,靶向治疗和联合治疗作为可能的解决方案,以减少毒性和增加这些有效的天然产物的治疗窗口。雷公藤
Triptolide and celastrol are predominantly active natural products isolated from the medicinal plant Tripterygium wilfordii Hook F. These compounds exhibit similar pharmacological activities, including anti-cancer, anti-inflammation, anti-obesity, and anti-diabetic activities. Triptolide and celastrol also provide neuroprotection and prevent cardiovascular and metabolic diseases. However, toxicity restricts the further development of triptolide and celastrol. In this review, we comprehensively review therapeutic targets and mechanisms of action, and translational study of triptolide and celastrol. We systemically discuss the structure-activity-relationship of triptolide, celastrol, and their derivatives. Furthermore, we propose the use of structural derivatives, targeted therapy, and combination treatment as possible solutions to reduce toxicity and increase therapeutic window of these potent natural products from T. wilfordii Hook F.
DOI: 10.1016/j.ejphar.2017.01.043
发表时间: 2017-03-15
影响因子: 5
作者:
Abu Bakar, Mohamad Hafizi;Sarmidi, Mohamad Roji;Rosdi, Mohamad Norisham Mohamad
通讯作者: Rosdi, Mohamad Norisham Mohamad
抗氧化活性和三墨晶提取物对人多巴胺能细胞中过氧化氢损伤的保护作用,SH-SY5Y。
DOI: 10.1007/s11064-010-0185-4
发表时间: 2010-08
影响因子: 4.4
作者:
Choi BS;Sapkota K;Kim S;Lee HJ;Choi HS;Kim SJ
通讯作者: Kim SJ
DOI: 10.3390/molecules19033508
发表时间: 2014-03-21
期刊: Molecules (Basel, Switzerland)
影响因子: --
作者:
Fan XX;Li N;Wu JL;Zhou YL;He JX;Liu L;Leung EL
通讯作者: Leung EL
DOI: 10.1097/cad.0b013e328337337c
发表时间: 2010-06-01
期刊: ANTI-CANCER DRUGS
影响因子: 2.3
作者:
Chen, Yuan-Wu;Lin, Gu-Jiun;Sytwu, Huey-Kang
通讯作者: Sytwu, Huey-Kang
DOI: 10.1016/j.surg.2014.04.055
发表时间: 2014-08-01
期刊: SURGERY
影响因子: 3.8
作者:
Alsaied, Osama A.;Sangwan, Veena;Jensen, Eric H.
通讯作者: Jensen, Eric H.